Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU

There would appear to be a strong interest in functional nuclear imaging for assessing the response to focal PaC treatment. Investigator team hypothesise that the diagnostic performance of PSMA PET is noninferior to that of MRI in detecting clinically significant recurrent PaC after treatment with HIFU. The main objective was to evaluate the diagnostic performance of PSMA PET compared with MRI with reference to the gold standard of prostate biopsy one year after HIFU.

NCT Number	NCT07766122
Lead Sponsor	University Hospital, Toulouse
Conditions	Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis)
Enrollment	30 participants
Start Date	2026-10
Primary Completion	2028-10 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-14